BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:IPS101A readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of IPS101A\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07371338-1664@assetmemo.bio
DTSTAMP:20261121T004521Z
DTSTART;VALUE=DATE:20280630
DTEND;VALUE=DATE:20280701
SUMMARY:IPS101A: Phase 1 readout est. (NCT07371338)
DESCRIPTION:IPS101A\, phase 1\, Parkinson's Disease.\nStudy: Phase 1 Clinic
 al Trial to Evaluate the Safety\, Efficacy\, and Pharmacokinetics of IPS10
 1A in Parkinson's Disease Patients\nEstimated primary completion: 30 June 
 2028. This is a ClinicalTrials.gov estimate\, not a confirmed readout date
 \, and it can move.\nDrug page: https://assetmemo.bio/drug/ips101a#upcomin
 g-events\nRegistry record: https://clinicaltrials.gov/study/NCT07371338
URL:https://assetmemo.bio/drug/ips101a#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
